Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1981-11-16
1984-04-24
Rosen, Sam
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
A61K 3700
Patent
active
044447574
ABSTRACT:
Methods are provided for the use of Thymus gland extracts, such as Thymosin, fraction 5, as an anti-autoimmune disease agent, useful in treating autoimmune diseases such as hypertension, lupus and diabetes. Thymosin, fraction 5, administration stimulated the development of a specific subclass of Thymus derived cells called Thymus suppressor cells which reduced the autoimmune state, thereby reducing hypertension, lupus, diabetes, and other autoimmune diseases.
REFERENCES:
patent: 4079127 (1978-03-01), Goldstein et al.
Marchalonis-Cancer Biology Reviews, vol. 1 (1980) pp. 79, 80, 84-87, 91-95.
Marshall et al.-Recent Results in Cancer Research, vol. 75 (1980) pp. 100-105.
Marshall et al.-Chem. Abst. vol. 94 (1980) p. 77089j.
Yu et al.-Chem. Abst. vol. 94 (1980) p. 28635a.
Trivers-Chem. Abst. vol. 93 (1980) pp. 68 273s.
Research Corporation
Rosen Sam
LandOfFree
Use of thymosin as an anti-diabetes and anti-hypertensive diseas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thymosin as an anti-diabetes and anti-hypertensive diseas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thymosin as an anti-diabetes and anti-hypertensive diseas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-115388